• News

    Results Found: 9
    Wednesday, December 02, 2020
    NCBIO has named David Etchison as its new communications director. Etchison has more than 25 years of experience in communications, public relations and marketing. He served as director of communications for the UNC Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill for 15 years and most recently ran email marketing for UNC-TV.  Etchison succeeds Brenda Summers, Ed.D., ...read more
    Categories: General News Article
    Wednesday, November 25, 2020
    A new executive order from the Trump administration that slashes Medicare payments to hospitals and physicians for certain medicines will hurt patients’ access to care and financially stress already overburdened hospitals and innovation-based pharmaceutical companies, according to NCBIO, the NC Biosciences Organization.   On Nov. 20, President Donald Trump announced an interim final rule with ...read more
    Categories: General News Article, Policy
    Thursday, November 19, 2020
    A COVID-resilient environment and clinical trials was the topic of discussion at a virtual forum hosted by NCBIO November 19.  The concept of virtual or decentralized trials has been around for a while, but COVID-19 forced companies and the FDA to act. Biopharma, regulatory and CRO representatives shared their perspectives on decentralized trials, their challenges and limitations, and on COVID-19 ...read more
    Categories: General News Article
    Wednesday, November 18, 2020
    Reducing steps to reduce carbon footprint and adopt other environmentally sustainable practices were among the topics shared at the quarterly Biotech Manufactures Forum. Biogen's Jennifer Wright, director, environment, health and safety, and Firoz Antia, director, ASO process development and manufacturing, outlined the company’s Healthy Climate, Healthy Lives program and planned investment of ...read more
    Categories: General News Article
    Tuesday, November 17, 2020
      Health Care Plans for Small Companies from NCBIO Your NCBIO membership unlocks access to NEW small group health plans available through the Biotechnology Innovation Organization. This valuable NCBIO benefit gives small life sciences companies with 5 to 50 employees the same flexibility, choice and reduced administrative costs typically available only to large corporations. BIO ...read more
    Categories: Advisory
    Tuesday, November 17, 2020
     Company Applications Now OpenMarch 23-25CED's 2021 Venture Connect Online features the addition of live streaming content, structured networking sessions, provocative speakers and more! This virtual gathering gives you access to innovation in the Southeast, spotlighting over 80 life science and tech companies that are scaling.With three days of continuous content, founders and CEOs will have the ...read more
    Categories: Advisory
    Thursday, November 12, 2020
    DURHAM, N.C. — Neal Fowler, CEO of Liquidia Technologies, has been named the new chairman of the NCBIO Board of Directors, and five new members have joined the board. New officers and the 2020-21 executive committee were elected at the board meeting Thursday, November 12.   “We are very pleased that Neal has agreed to serve as our board chair,” said Sam Taylor, president of NCBIO, the North ...read more
    Categories: General News Article
    Wednesday, October 28, 2020
    Single-use supply chain strategy, moving to an electronic quality management system and applying AI and machine learning to microscopy were the topics discussed during the Virtual BIO Business Solutions Spotlight webinar presented by the NC Biosciences Organization for its members Wednesday, Oct. 28. Timothy Korwan, director, new product innovation for Avantor Fluid Handling Solutions, took ...read more
    Categories: General News Article
    Monday, October 05, 2020
    Four days of sessions on elections, policies, COVID-19 and more comprised the 2020 NCBIO Annual Meeting held Sept. 29 to Oct. 2.  “We are living through extraordinary challenges,” BIO CEO  Dr. Michelle McMurry-Heath said during the closing session of NCBIO Annual Meeting. “I  hope it is a turning point in the public’s understanding of why science matters. Biotech and science are the catalysts ...read more
    Categories: General News Article
  • Mark Your Calendars